ArticleDer Pathologe2011
[Ductal and lobular preneoplasia: role in breast cancer development].
Article in Der Pathologe, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWith the widespread use of screening mammography and core needle biopsies, preneoplastic lesions of the breast are observed with increasing frequency. Unlike low-grade ductal carcinoma in situ (lg-DCIS), a possible precursor role of atypical ductal hyperplasia (ADH), lobular neoplasia (LN), and flat epithelial atypia (FEA) as well as their risk of progression have not been clearly defined. The aim of the present study was to evaluate the biological potential of these early low-grade lesions in the development of breast cancer. MATERIALS AND
methodsDifferent series of precursor lesions and syn- or metachronous invasive carcinomas were tested for clonality using mitochondrial DNA sequencing, analysis of E-cadherin inactivation and comparative allelotyping with a panel of 14 polymorphous STR markers.
resultsIn a series of invasive carcinomas occurring up to 10 years after the initial diagnosis of lobular neoplasia, a direct (clonal) association was established between LN and 3 of 5 invasive lobular cancers (ILC) but not in any of the cases with ductal secondary tumors. Tests on lg-DCIS and FEA occurring in association with tubular breast carcinomas demonstrated a direct clonal relationship in 67 and 70% of cases, respectively, and comparative allelotyping revealed a high degree of homology in the patterns of chromosomal imbalances. In addition, FEA and lg-DCIS, but not LN, were frequently closely related with each other.
conclusionThe present data provide molecular evidence for a direct clonal relationship of LN and ILC as well as of FEA and lg-DCIS with tubular breast carcinomas. However, the multifocal occurrence and frequent coexistence of the different precursor lesions suggests the presence of (possibly hormone-induced) field effects on the breast parenchyma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.